Yifei Tao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yifei Tao has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Chan Chen
Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
1 shared publication - Changteng Zhang
Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
1 shared publication Hai Chen
Department of Respiratory and Critical Care Medicine, Targeted Tracer Research and Development Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan, China
1 shared publicationJiangning Song
Monash Biomedicine Discovery Institute and Monash Data Futures Institute, Monash University, Melbourne, Australia
1 shared publicationJin Liu
Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
1 shared publication- Kewen Ding
Department of Anesthesiology, The Research Units of West China (2018RU012), Chinese Academy of Medical Sciences, West China Hospital, Sichuan University, Chengdu, Sichuan, China
1 shared publication
Latest Publications
- Open Access
- 4 June 2026
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 145 (4) , 857-871
Genetic contributors to postoperative delirium and their implications for dementia outcomes
Background: Postoperative delirium (POD) is a perioperative neurocognitive disorder that substantially impairs patient recovery. Unfortunately, its genetic risk profile and relationship with subsequent dementia remain unclear. We aimed to elucidate genetic contributors to POD identified via Hospital Episode Statistics codes and to examine its association with subsequent dementia. Methods: We included 230,179 non-cardiac and 21,254 cardiac surgery subjects from the UK Biobank, defining POD using ICD-10 delirium codes recorded within the first 7 postoperative days. Genome-wide association studies (GWAS) were performed in the non-cardiac and cardiac cohorts and their prespecified subgroups, followed by functional annotation, gene prioritization and drug-target analyses. Associations between POD and subsequent dementia were estimated using Cox models. Results: In the non-cardiac cohort, we identified one genome-wide significant locus at the APOE region, with rs429358 as the lead variant ( P =5.00×10 -28 ). Integrative gene prioritization analyses highlighted multiple genes within this locus. Exploratory drug-target analyses suggested potential subgroup-specific drug-target enrichment. In the cardiac cohort, no genome-wide significant signals were detected. POD was associated with all-cause dementia after both non-cardiac (HR=6.45, 95% CI 5.45-7.63) and cardiac (HR=2.95, 95% CI 1.71-5.08) surgeries. Conclusions: This study demonstrates APOE as a genetic risk locus for ICD-coded POD in the non-cardiac surgery setting and confirms an association between POD and subsequent dementia.
- 4 June 2026
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 145 (4) , 857-871
Open AccessGenetic contributors to postoperative delirium and their implications for dementia outcomes
Background: Postoperative delirium (POD) is a perioperative neurocognitive disorder that substantially impairs patient recovery. Unfortunately, its genetic risk profile and relationship with subsequent dementia remain unclear. We aimed to elucidate genetic contributors to POD identified via Hospital Episode Statistics codes and to examine its association with subsequent dementia. Methods: We included 230,179 non-cardiac and 21,254 cardiac surgery subjects from the UK Biobank, defining POD using ICD-10 delirium codes recorded within the first 7 postoperative days. Genome-wide association studies (GWAS) were performed in the non-cardiac and cardiac cohorts and their prespecified subgroups, followed by functional annotation, gene prioritization and drug-target analyses. Associations between POD and subsequent dementia were estimated using Cox models. Results: In the non-cardiac cohort, we identified one genome-wide significant locus at the APOE region, with rs429358 as the lead variant ( P =5.00×10 -28 ). Integrative gene prioritization analyses highlighted multiple genes within this locus. Exploratory drug-target analyses suggested potential subgroup-specific drug-target enrichment. In the cardiac cohort, no genome-wide significant signals were detected. POD was associated with all-cause dementia after both non-cardiac (HR=6.45, 95% CI 5.45-7.63) and cardiac (HR=2.95, 95% CI 1.71-5.08) surgeries. Conclusions: This study demonstrates APOE as a genetic risk locus for ICD-coded POD in the non-cardiac surgery setting and confirms an association between POD and subsequent dementia.